Virtu Financial’s PAVmed Inc. Series Z Warrant PAVMZ Stock Holding History

Virtu Financial’s Portfolio PAVMZ Stock Details PAVMZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-21,808	Closed	-$151K	–	2268
2021 Q3	$151K	Buy	+21,808	New	+$118K	0.01%	1008
2020 Q3	–	Sell	-13,343	Closed	-$14K	–	1612
2020 Q2	$14K	Buy	+13,343	New	+$14.7K	﹤0.01%	1164

Other funds holding PAVMZ

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu Financial's PAVMZ Position: Q4 2021 in Review

Virtu Financial sold out of PAVmed Inc. Series Z Warrant (PAVMZ) in Q4 2021, closing a stake of 21,808 shares — an estimated $151K sold.

Virtu Financial first reported a position in PAVMZ in Q2 2020 and held it in 2 quarters. The position peaked at $151K in Q3 2021. 7 funds tracked by Wall St. Rank hold PAVMZ as of Q4 2021.

Virtu Financial reported no remaining PAVmed Inc. Series Z Warrant position as of Q4 2021 after selling out during the quarter.
Virtu Financial sold 21,808 PAVmed Inc. Series Z Warrant shares in Q4 2021, an estimated $151K.
Virtu Financial first reported a position in PAVmed Inc. Series Z Warrant in Q2 2020 and held it in 2 quarters.
Virtu Financial's PAVmed Inc. Series Z Warrant position peaked at $151K in Q3 2021.
7 funds tracked by Wall St. Rank held PAVmed Inc. Series Z Warrant as of Q4 2021.

Based on Virtu Financial's 13F filing for Q4 2021, filed 17 Feb 2022.